±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 268  |  »Ø¸´: 0

bxzc123

½ð³æ (ÕýʽдÊÖ)

[ÇóÖú] Çó·­ÒëÒ»¶Î»°£¬Ð»Ð»£¬Õ¾ÄÚÐÅ

Abstract
Actinomycetes have been prolific sources of novel secondary metabolites with a range of biologi-
cal activities that may ultimately find application as therapeutic compounds. Hence several drug
discovery companies are engaged in isolation of novel bioactive metabolites from these microbial
sources. Antibiotics form the major class of such bioactive metabolites and have been widely used
for treating infectious diseases. One of the most critical problems in clinical practice is the in-
crease of prevalence of drug resistant strains, especially azole resistance among fungi. Due to this,
there is a constant need for development of new antifungal antibiotics having novel scaffolds
and/or mechanism of action. In our in-house screening program in the quest of novel and superior
antifungal compounds, an actinomycetes strain PM0525875 was isolated from a marine inverte-
brate. The extracts of this microbe showed potent in-vitro antifungal activity against drug resis-
tant fungal strains. The antifungal active peak from the extract obtained by shake flask fermenta-
tion was identified by chromatographic and other analytical techniques during bioactivity guided
isolation. Later the fermentation conditions were optimized in 30 L fermentor for the production
of sufficient amount antifungal compound for complete structural characterization. Consequently
the fermented broth extract was subjected to bioactivity-guided fractionation, to isolate the active
principle using different preparative chromatographic techniques followed by its characterization.
The active principle was characterized to be Caerulomycin A. Minimum inhibitory concentration
(MIC) of the compound was found in the range of 0.39 - 1.56 ¦Ìg/ml against pathogenic fungal test
strains. The phylogenetic analysis of producer strain using 16S rRNA sequence showed closest
match with Actinoalloateichus cyanogriseus. Herewith we report the isolation of Caerulomycin A
from marine invertebrate-associated Actinoalloteichus sp. using optimized medium and fermenta-
tion conditions.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ bxzc123 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Àè°ÉÀ²À²ÄãºÜÓÐà 2026-04-03 7/350 2026-04-05 17:18 by Hdyxbekcb
[¿¼ÑÐ] 275Çóµ÷¼Á +16 waltzh 2026-04-01 16/800 2026-04-05 17:14 by Hdyxbekcb
[¿¼ÑÐ] 304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£© +15 »¯¹¤ÈË999 2026-04-04 15/750 2026-04-05 16:25 by ÎÒÊǵç·çÉÈr
[¿¼ÑÐ] 313Çóµ÷¼Á +5 º£ÈÕº£ÈÕ 2026-04-04 7/350 2026-04-05 13:58 by imissbao
[¿¼ÑÐ] 070300»¯Ñ§Çóµ÷¼Á +17 С»ÆÑ¼±¦ 2026-03-30 17/850 2026-04-05 12:03 by Äþܰ¹þ¹þ
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á325·Ö +9 15771691647 2026-04-04 9/450 2026-04-05 11:39 by Öí»á·É
[¿¼ÑÐ] 083200 333Çóµ÷¼Á +3 Ê®¶þ£¡£¡ 2026-04-04 3/150 2026-04-05 08:28 by barlinike
[¿¼ÑÐ] 323·Ö£¨¼ÆËã»úÊÓ¾õºÍ´óÄ£ÐÍÏîÄ¿£©ÄÜÖ±½ÓÉÏÊÖ +3 chaoxiicy 2026-04-01 3/150 2026-04-05 00:50 by chongya
[¿¼ÑÐ] ²ÄÁÏר˶306Ó¢Ò»Êý¶þ +8 z1z2z3879 2026-03-31 8/400 2026-04-04 22:08 by hemengdong
[¿¼ÑÐ] ²ÄÁÏ295 +13 СӢ11 2026-04-03 14/700 2026-04-04 09:02 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] 305Çóµ÷¼Á +3 77Qi 2026-04-03 3/150 2026-04-03 23:01 by qzxyhcsy
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 Draa 2026-04-03 3/150 2026-04-03 17:37 by hgwz7468
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬×Ü·Ö320Çóµ÷¼Á +7 À§À§À§À§À¤À¤ 2026-04-02 7/350 2026-04-03 17:26 by Yuena_Wang
[¿¼ÑÐ] 260Çóµ÷¼Á +3 ÖìÜÆÁÕ 2026-04-02 3/150 2026-04-03 08:44 by yulian1987
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +6 ´ó²öС×Ó 2026-04-02 6/300 2026-04-02 21:54 by dongzh2009
[¿¼ÑÐ] 298ÇóBÇøµ÷¼Á +4 zzz£¬£¬r 2026-04-02 5/250 2026-04-02 12:17 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +10 @taotao 2026-03-31 11/550 2026-04-01 09:43 by xiayizhi
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷½»´ó080500²ÄÁÏѧ˶349 +6 jqx1258 2026-03-31 7/350 2026-03-31 21:08 by yuq
[¿¼ÑÐ] Ó¢Ò»ÊýÒ»×Ü·Ö334Çóµ÷¼Á +4 ³ÂÑôÀ¤ 2026-03-31 4/200 2026-03-31 14:22 by ¼Çʱ¾2026
[¿¼ÑÐ] 085404 22408 315·Ö +5 zhuangyan123 2026-03-31 6/300 2026-03-31 13:48 by limeifeng
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û